Fiche centre
China-Japan Friendship Hospital
Beijing — China
Essais liés8clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06459427
Essais cliniques associés
8| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Ferric derisomaltose | Insuffisance cardiaque | Phase 4 | NCT05991128 | COREVIVE-HFpEF — The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life | RECRUITING |
| Ferric derisomaltose | Maladie coronarienne | Phase 4 | NCT05971732 | The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF) | RECRUITING |
| Robot-assisted minimally invasive puncture and aspiration surgery | Accident vasculaire cérébral | Non applicable | NCT06459427 | RAINBOW-BSH — A Multicenter, RAndomIzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With AI-assisted Robotic guidanCe for Hemorrhagic Stroke | RECRUITING |
| Nerandomilast | Myopathies | Phase 3 | NCT07789015 | VERANDA™-IIM — A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | NOT_YET_RECRUITING |
| KarXT | Alzheimer | Phase 3 | NCT06585787 | A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) | RECRUITING |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |
| Equecabtagene Autoleucel Injection (Eque-cel) | Myopathies | Phase 1/2 | NCT07752264 | A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy | NOT_YET_RECRUITING |
| Extend LymphAdenectomy | Cancer | NA | NCT04078230 | Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma | RECRUITING |